United States Malaria Drugs Market Report 2018

January 2018 | 96 pages | ID: UE513E9FF0EEN
QYResearch

Abstracts

In this report, the United States Malaria Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Malaria Drugs in these regions, from 2013 to 2025 (forecast).

United States Malaria Drugs market competition by top manufacturers/players, with Malaria Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma
• Kunming Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prevention
• Treatment
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Malaria Drugs Market Report 2018

1 MALARIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Malaria Drugs
1.2 Classification of Malaria Drugs by Product Category
  1.2.1 United States Malaria Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Malaria Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Aryl Aminoalcohol Compounds
  1.2.4 Antifolate Compounds
  1.2.5 Artemisinin Compounds
1.3 United States Malaria Drugs Market by Application/End Users
  1.3.1 United States Malaria Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Prevention
  1.3.3 Treatment
  1.3.4 Other
1.4 United States Malaria Drugs Market by Region
  1.4.1 United States Malaria Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Malaria Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Malaria Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Malaria Drugs Status and Prospect (2013-2025)
  1.4.5 New England Malaria Drugs Status and Prospect (2013-2025)
  1.4.6 The South Malaria Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Malaria Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Malaria Drugs (2013-2025)
  1.5.1 United States Malaria Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Malaria Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES MALARIA DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Malaria Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Malaria Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Malaria Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Malaria Drugs Market Competitive Situation and Trends
  2.4.1 United States Malaria Drugs Market Concentration Rate
  2.4.2 United States Malaria Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Malaria Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MALARIA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Malaria Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Malaria Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Malaria Drugs Price by Region (2013-2018)

4 UNITED STATES MALARIA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Malaria Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Malaria Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Malaria Drugs Price by Type (2013-2018)
4.4 United States Malaria Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES MALARIA DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Malaria Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Malaria Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES MALARIA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Cipla
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Malaria Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cipla Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Guilin Pharmaceutical
  6.2.2 Malaria Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Guilin Pharmaceutical Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 IPCA Laboratories
  6.3.2 Malaria Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 IPCA Laboratories Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.2 Malaria Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Mylan Labs
  6.5.2 Malaria Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Labs Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.2 Malaria Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.2 Malaria Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Sanofi Aventis
  6.8.2 Malaria Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Aventis Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Ajanta Pharma
  6.9.2 Malaria Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ajanta Pharma Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Kunming Pharmaceutical
  6.10.2 Malaria Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Kunming Pharmaceutical Malaria Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 MALARIA DRUGS MANUFACTURING COST ANALYSIS

7.1 Malaria Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Malaria Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Malaria Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Malaria Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MALARIA DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Malaria Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Malaria Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Malaria Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Malaria Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Malaria Drugs
Figure United States Malaria Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Malaria Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Aryl Aminoalcohol Compounds Product Picture
Figure Antifolate Compounds Product Picture
Figure Artemisinin Compounds Product Picture
Figure United States Malaria Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Malaria Drugs by Application in 2017
Figure Prevention Examples
Table Key Downstream Customer in Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Malaria Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Malaria Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Malaria Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Malaria Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Malaria Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Malaria Drugs Sales Share by Players/Suppliers
Figure 2017 United States Malaria Drugs Sales Share by Players/Suppliers
Figure United States Malaria Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Malaria Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Malaria Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Malaria Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Malaria Drugs Revenue Share by Players/Suppliers
Table United States Market Malaria Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Malaria Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Malaria Drugs Market Share of Top 3 Players/Suppliers
Figure United States Malaria Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Malaria Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Malaria Drugs Product Category
Table United States Malaria Drugs Sales (K Units) by Region (2013-2018)
Table United States Malaria Drugs Sales Share by Region (2013-2018)
Figure United States Malaria Drugs Sales Share by Region (2013-2018)
Figure United States Malaria Drugs Sales Market Share by Region in 2017
Table United States Malaria Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Malaria Drugs Revenue Share by Region (2013-2018)
Figure United States Malaria Drugs Revenue Market Share by Region (2013-2018)
Figure United States Malaria Drugs Revenue Market Share by Region in 2017
Table United States Malaria Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Malaria Drugs Sales (K Units) by Type (2013-2018)
Table United States Malaria Drugs Sales Share by Type (2013-2018)
Figure United States Malaria Drugs Sales Share by Type (2013-2018)
Figure United States Malaria Drugs Sales Market Share by Type in 2017
Table United States Malaria Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Malaria Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Malaria Drugs by Type (2013-2018)
Figure Revenue Market Share of Malaria Drugs by Type in 2017
Table United States Malaria Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Malaria Drugs Sales Growth Rate by Type (2013-2018)
Table United States Malaria Drugs Sales (K Units) by Application (2013-2018)
Table United States Malaria Drugs Sales Market Share by Application (2013-2018)
Figure United States Malaria Drugs Sales Market Share by Application (2013-2018)
Figure United States Malaria Drugs Sales Market Share by Application in 2017
Table United States Malaria Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Malaria Drugs Sales Growth Rate by Application (2013-2018)
Table Cipla Basic Information List
Table Cipla Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cipla Malaria Drugs Sales Growth Rate (2013-2018)
Figure Cipla Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Cipla Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Guilin Pharmaceutical Basic Information List
Table Guilin Pharmaceutical Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Guilin Pharmaceutical Malaria Drugs Sales Growth Rate (2013-2018)
Figure Guilin Pharmaceutical Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Guilin Pharmaceutical Malaria Drugs Revenue Market Share in United States (2013-2018)
Table IPCA Laboratories Basic Information List
Table IPCA Laboratories Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure IPCA Laboratories Malaria Drugs Sales Growth Rate (2013-2018)
Figure IPCA Laboratories Malaria Drugs Sales Market Share in United States (2013-2018)
Figure IPCA Laboratories Malaria Drugs Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Malaria Drugs Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Malaria Drugs Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Mylan Labs Basic Information List
Table Mylan Labs Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan Labs Malaria Drugs Sales Growth Rate (2013-2018)
Figure Mylan Labs Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Mylan Labs Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Malaria Drugs Sales Growth Rate (2013-2018)
Figure Roche Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Roche Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Malaria Drugs Sales Growth Rate (2013-2018)
Figure Novartis Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Novartis Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Sanofi Aventis Basic Information List
Table Sanofi Aventis Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Aventis Malaria Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Aventis Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi Aventis Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Ajanta Pharma Basic Information List
Table Ajanta Pharma Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ajanta Pharma Malaria Drugs Sales Growth Rate (2013-2018)
Figure Ajanta Pharma Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Ajanta Pharma Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Kunming Pharmaceutical Basic Information List
Table Kunming Pharmaceutical Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kunming Pharmaceutical Malaria Drugs Sales Growth Rate (2013-2018)
Figure Kunming Pharmaceutical Malaria Drugs Sales Market Share in United States (2013-2018)
Figure Kunming Pharmaceutical Malaria Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Malaria Drugs
Figure Manufacturing Process Analysis of Malaria Drugs
Figure Malaria Drugs Industrial Chain Analysis
Table Raw Materials Sources of Malaria Drugs Major Players/Suppliers in 2017
Table Major Buyers of Malaria Drugs
Table Distributors/Traders List
Figure United States Malaria Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Malaria Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Malaria Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Malaria Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Malaria Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Malaria Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Malaria Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Malaria Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Malaria Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Malaria Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Malaria Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Malaria Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Malaria Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources